| Literature DB >> 11746631 |
Abstract
Neuroleptic malignant syndrome is a serious complication of levodopa withdrawal in patients with Parkinson's disease. We report a patient with advanced parkinsonism who developed neuroleptic malignant syndrome in the setting of inadequate levodopa intake. His symptoms improved with levodopa replacement, but dramatically worsened when enteral feeding was begun due to interference with intestinal absorption of levodopa. Copyright 2001 Movement Disorder Society.Entities:
Mesh:
Substances:
Year: 2001 PMID: 11746631 DOI: 10.1002/mds.1166
Source DB: PubMed Journal: Mov Disord ISSN: 0885-3185 Impact factor: 10.338